Trident Lifeline

{
  "main_header": {
    "sid": 1003715,
    "name": "Trident Lifeline",
    "stock_name": "Trident Lifeline",
    "full_name": "Trident Lifeline Ltd",
    "name_url": "stocks-analysis/trident-lifeline",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "290.25",
    "chg": -12.75,
    "chgp": "-4.21%",
    "dir": -1,
    "prev_price": "303.00",
    "mcapval": "362.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543616,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0MKA01014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": 6000,
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trident-lifeline-1003715-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Trident Lifeline Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-hold-by-marketsmojo-3804025",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TridentLifeline_mojoScore_3804025.png",
        "date": "2026-01-25 10:10:30",
        "description": "Trident Lifeline Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Trident Lifeline Q3 FY26: Strong Revenue Growth Masks Margin Pressure and Profit Decline",
        "link": "https://www.marketsmojo.com/news/result-analysis/trident-lifeline-q3-fy26-strong-revenue-growth-masks-margin-pressure-and-profit-decline-3794672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TridentLifeline_quaterlyResult_3794672.png",
        "date": "2026-01-19 13:31:59",
        "description": "Trident Lifeline Ltd., a micro-cap pharmaceutical company specialising in marketing ethical pharmaceutical products domestically and internationally, reported mixed results for Q3 FY26, with consolidated net profit declining 13.13% quarter-on-quarter to ₹4.30 crores despite robust revenue growth. The company, with a market capitalisation of ₹363.96 crores, saw its stock trading at ₹305.00 on January 19, 2026, down 0.57% from the previous close, reflecting investor concerns over deteriorating profitability metrics and rising operational costs."
      },
      {
        "title": "Trident Lifeline Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-buy-3791800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TridentLifeline_mojoScore_3791800.png",
        "date": "2026-01-14 10:10:37",
        "description": "Trident Lifeline Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 14 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Trident Lifeline Ltd Hits New 52-Week High at Rs.328",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-hits-new-52-week-high-at-rs328-3781957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TridentLifeline_priceRelatedfactors_3781957.png",
        "date": "2026-01-05 10:51:35",
        "description": "Trident Lifeline Ltd has surged to a fresh 52-week high of Rs.328, marking a significant milestone in its stock performance. This achievement reflects sustained momentum driven by robust financial results and positive market dynamics within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Trident Lifeline Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-ltd-is-rated-buy-3779919",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TridentLifeline_mojoScore_3779919.png",
        "date": "2026-01-03 10:10:34",
        "description": "Trident Lifeline Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Trident Lifeline Ltd Hits New 52-Week High at Rs.327",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifeline-ltd-hits-new-52-week-high-at-rs327-3778625",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TridentLifeline_priceRelatedfactors_3778625.png",
        "date": "2026-01-02 09:53:13",
        "description": "Trident Lifeline Ltd has surged to a fresh 52-week high of Rs.327, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. The stock’s recent rally underscores sustained gains and positive financial performance, setting a notable milestone for the company."
      },
      {
        "title": "Why is Trident Lifeline Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-trident-lifeline-ltd-fallingrising-3768848",
        "imagepath": "",
        "date": "2025-12-25 02:13:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock’s performance on 24-Dec was notably weak, underperforming its sector by 8.35%. Intraday volatility was high, with the share price swinging within a wide range of ₹34 and touching a low of ₹265, representing an 11.07% drop from previous levels. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure among investors.</p>\n<p>When compared to the benchmark Sensex, which gained 1.00% over the past week and 0.60% over the last month, Trident Lifeline’s returns have been disappointing. The stock declined by 7.08% in the past week and 9.08% over the last month, underperforming the market consistently. Year-to-date, the stock is down 2.91%, while the Sensex has..."
      },
      {
        "title": "Trident Lifeline’s Evaluation Revised Amid Strong Financial and Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-quality-metrics-3767020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TridentLifeline_mojoScore_3767020.png",
        "date": "2025-12-23 10:10:16",
        "description": "Trident Lifeline, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its market assessment, reflecting shifts in its financial health, valuation, and technical outlook. This adjustment highlights evolving investor perspectives amid the company’s notable operational performance and market behaviour."
      },
      {
        "title": "Trident Lifeline Sees Revision in Market Evaluation Amid Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-quality-metrics-3741253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TridentLifeline_mojoScore_3741253.png",
        "date": "2025-12-02 10:09:20",
        "description": "Trident Lifeline, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, technical outlook, and overall quality, signalling renewed investor interest and a changing market perspective."
      }
    ],
    "total": 125,
    "sid": "1003715",
    "stock_news_url": "https://www.marketsmojo.com/news/trident-lifeline-1003715"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "02-Feb-2026",
      "details": "We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421) a subsidiary company has allotted Bonus shares to their existing members. Pursuant to the above bonus allotment of 934160 new shares to Trident Lifeline Limited the shareholding of Trident Lifeline Limited in Trident Mediquip Limited remains same at 60.04%.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "20-Jan-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Earnings Presentation for the quarter ended 31st December 2025 (Q3FY26).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "19-Jan-2026",
      "details": "In accordance with Regulation 47 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations we hereby enclose copies of newspaper advertisement published on January 19 2026 regarding extract of the Un-Audited Standalone and Consolidated Financial Statements for the quarter ended 31st December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Trident Lifeline Ltd is Rated Hold by MarketsMOJO

2026-01-25 10:10:30

Trident Lifeline Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Trident Lifeline Q3 FY26: Strong Revenue Growth Masks Margin Pressure and Profit Decline

2026-01-19 13:31:59

Trident Lifeline Ltd., a micro-cap pharmaceutical company specialising in marketing ethical pharmaceutical products domestically and internationally, reported mixed results for Q3 FY26, with consolidated net profit declining 13.13% quarter-on-quarter to ₹4.30 crores despite robust revenue growth. The company, with a market capitalisation of ₹363.96 crores, saw its stock trading at ₹305.00 on January 19, 2026, down 0.57% from the previous close, reflecting investor concerns over deteriorating profitability metrics and rising operational costs.

Read full news article

Trident Lifeline Ltd is Rated Buy

2026-01-14 10:10:37

Trident Lifeline Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 14 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Trident Lifeline Ltd Hits New 52-Week High at Rs.328

2026-01-05 10:51:35

Trident Lifeline Ltd has surged to a fresh 52-week high of Rs.328, marking a significant milestone in its stock performance. This achievement reflects sustained momentum driven by robust financial results and positive market dynamics within the Pharmaceuticals & Biotechnology sector.

Read full news article

Trident Lifeline Ltd is Rated Buy

2026-01-03 10:10:34

Trident Lifeline Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Trident Lifeline Ltd Hits New 52-Week High at Rs.327

2026-01-02 09:53:13

Trident Lifeline Ltd has surged to a fresh 52-week high of Rs.327, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. The stock’s recent rally underscores sustained gains and positive financial performance, setting a notable milestone for the company.

Read full news article

Why is Trident Lifeline Ltd falling/rising?

2025-12-25 02:13:56

Recent Price Movement and Market Comparison

The stock’s performance on 24-Dec was notably weak, underperforming its sector by 8.35%. Intraday volatility was high, with the share price swinging within a wide range of ₹34 and touching a low of ₹265, representing an 11.07% drop from previous levels. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure among investors.

When compared to the benchmark Sensex, which gained 1.00% over the past week and 0.60% over the last month, Trident Lifeline’s returns have been disappointing. The stock declined by 7.08% in the past week and 9.08% over the last month, underperforming the market consistently. Year-to-date, the stock is down 2.91%, while the Sensex has...

Read full news article

Trident Lifeline’s Evaluation Revised Amid Strong Financial and Technical Indicators

2025-12-23 10:10:16

Trident Lifeline, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its market assessment, reflecting shifts in its financial health, valuation, and technical outlook. This adjustment highlights evolving investor perspectives amid the company’s notable operational performance and market behaviour.

Read full news article

Trident Lifeline Sees Revision in Market Evaluation Amid Strong Financial Trends

2025-12-02 10:09:20

Trident Lifeline, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, technical outlook, and overall quality, signalling renewed investor interest and a changing market perspective.

Read full news article

View All News